Cargando…
In Vitro Virucidal Effect of Intranasally Delivered Chlorpheniramine Maleate Compound Against Severe Acute Respiratory Syndrome Coronavirus 2
Background The initial global outbreak of the novel coronavirus disease 2019 (COVID-2019) pandemic, which is responsible for the severe acute respiratory syndrome 2 (SARS-CoV-2), shares similarities with the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrom...
Autores principales: | Westover, Jonna B, Ferrer, Gustavo, Vazquez, Hector, Bethencourt-Mirabal, Arian, Go, Camille Celeste |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500730/ https://www.ncbi.nlm.nih.gov/pubmed/32963923 http://dx.doi.org/10.7759/cureus.10501 |
Ejemplares similares
-
A Randomized Controlled Pilot Trial to Test the Efficacy of Intranasal Chlorpheniramine Maleate With Xylitol for the Treatment of Allergic Rhinitis
por: Sanchez-Gonzalez, Marcos, et al.
Publicado: (2021) -
Anaphylaxis to Chlorpheniramine Maleate and Literature Review
por: Choi, Yong Won, et al.
Publicado: (2019) -
A Case of Chlorpheniramine Maleate-Induced Hypersensitivity With Aspirin Intolerance
por: Kim, Min-Hye, et al.
Publicado: (2011) -
Compatibility study of paracetamol, chlorpheniramine maleate and phenylephrine hydrochloride in physical mixtures
por: de Oliveira, G.G.G., et al.
Publicado: (2017) -
Allergic contact dermatitis following drug rash due to chlorpheniramine maleate
por: Shikino, Kiyoshi, et al.
Publicado: (2017)